Secondary Logo

Journal Logo

Information for Authors

Please note, all submissions to JDNA must be submitted via our online submission portal​.


SCOPE

The Journal of the Dermatology Nurses’ Association (JDNA) is the official journal of the Dermatology Nurses’ Association (DNA). JDNA’s mission is to support nursing practice, research, education, and advocacy through the dissemination of scholarly, cutting-edge, evidence-based articles with evolving knowledge and practice standards.

JDNA provides a forum for multidisciplinary discussions related to all aspects of dermatology nursing and practice, including clinical practice, education, research, prevention, public health, health administration, international health, legal-ethical issues, social issues, health equity, and public policy. We invite original articles that focus on a broad spectrum of issues related to dermatology nursing, from the perspectives of nursing, public health, behavioral health, and medicine. Submissions are welcomed from nurses and other health care professionals, as well as from multidisciplinary teams.

JDNA seeks to publish original articles, focused on topics of interest to dermatology nurses, that:

Create a global forum for authors to share results, methods, innovations, and expert opinions.
Contribute to improved standards of care.
Critically review and advance the state of the science.
Provide an interactive forum for translating evidence-based, clinically-relevant, and peer-reviewed research into practice.
Represent a broad range of clinical care, research, education, and advocacy issues.
Reflect the multi-professional nature of health and mental health care.
Emphasize the vital roles of nurses in transforming global health, including clinical care, policy development, education, research, and advocacy.

All materials submitted for review must be original and unpublished. Any material submitted for review is done with the understanding that it has not been submitted to any other journals simultaneously. The author is responsible for notifying the editor if data from submitted research has been used in other publications. ​



TYPES OF ARTICLES

JDNA invites contributions in the forms of (a)original research and state-of-the-knowledge reviews; (b) research, practice, education, and program briefs; (c) case reports; (d) topical columns and commentaries; (e) guest editorials (invited); (f) media and book reviews; and (g) letters to the editor.

The editor reviews these submissions and determines whether input is needed from additional reviewers.

Submissions should include the following, submitted as separate files: (a) title page; (b) manuscript body that includes, in this order: abstract and 3-6 key words (on first page), title (on page 2, centered and not bolded), manuscript text (with appropriate headers), references and key considerations, (c) tables, if applicable; and (d) figures if applicable. 

 These submissions should have the following components submitted as separate files: (a) title page that includes 3-6 key words, submitted in a separate file; (b) manuscript body that includes the following items in this order: title (centered and not bolded), text, references, and tables, if applicable; and (c) figures, if applicable, in a separate file. 

Reporting Guidelines

JDNA requires that authors use the following industry-recognized reporting guidelines to assure that minimum reporting requirements are met. The checklist for each guideline must be uploaded with your manuscript files. For further information on reporting guidelines, visit www.equator-network.org.

  1. Systematic reviews with or without meta-analysis: Authors should utilize a systematic approach to finding relevant studies, such as the PRISMA Statement, the Joanna Briggs Institute, or the Cochrane Collaboration. The system utilized for the review should be described in the article, including search strategies, inclusion/exclusion criteria, and evaluation of the strength of the reported research. Lengthy tables reporting study findings should be included as online supporting information.
  2. Qualitative Research: In qualitative research, the type of analysis and control for rigor and credibility must be clearly stated. Any identifying information in responses from subjects must be removed. The Equator Network may be helpful to authors who are looking to publish qualitative research findings.
  3. Observational Studies (cohort, case-control, cross-sectional): Review the STROBE statement for guidelines for reporting observational studies.
  4. Quality Improvement Research: This must be clearly differentiated from experimental design. Recommendations for reporting a QI research project can be found under the SQUIRE guidelines.
  5. Parallel Group Randomized Trials: Use the CONSORT guidelines to report experimental research and include the trial registration number. Note that there are supporting files for extensions of the CONSORT guidelines to address specific issues in other types of experimental design, such as trials assessing non-pharmacologic treatments.
Study TypeReporting GuidelineLink to Guideline
Randomized Controlled Trial (RTC)CONSORT

Checklist

Flowchart

Systematic Reviews or Meta-analyses of RTCsPRISMA

Checklist

Flowchart

Quality Improvement (QI)SQUIRE

Statement

Checklist

Systematic approach to reporting about sex and gender in researchSAGER

Guideline

Checklist (see Appendix 2)

 

Authorship

Each person listed as an author is expected to have participated in the work to a significant extent according to the International Committee for Medical Journal Editors' (ICMJE) authorship criteria. Authors should meet ALL of the following conditions:

  1. substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data
  2. drafting the manuscript or revising it critically for important intellectual content
  3. final approval of the version to be published
  4. agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Authorship and the order of authors are established in the initial manuscript submission. Any changes must be formally requested in a letter listing (a) newly added or deleted authors and/or a change in the order of the previously listed authors, and (b) the reason for the change. All of the manuscript's originally listed authors (including any who are being removed from the list), as well as any newly-added authors, must sign the request to signify agreement to the change. The corresponding author should email this information to all of the authors and copy the editorial office. Each author should then reply to all with his/her approval.

Individuals who have not contributed sufficiently to the manuscript or do not meet the ICMJE criteria should not be included in the author list. Instead, these individuals should be named, with a statement of what they contributed to the work, in the Acknowledgments Statement on the Title Page.​

For helpful examples of author and contributor roles, click here.

Manuscript Submission

Manuscripts for JDNA must be submitted via our Editorial Manager portal, where you will be prompted to reguster and log-in as an author.

Manuscript Preparation: Manuscripts should use a 12-font Time New Roman, double-spaced, with one inch margins. A checklist for manuscript format is included below. JDNA follows the style of the Publication Manual of the American Psychological Association (APA), 7th edition.

1. Title page: Title of manuscript, name of author(s), degree (s) and certifications, authors’ institutional affiliation and professional positions. Give a complete mailing address, business phone number, home phone number, fax number, and e-mail address, and the 'Conflicts of Interest and Source of Funding.' Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest, in addition to sources of funding. If there is no conflict of interest, this should also be explicitly stated as none declared. 

For example:

Conflicts of Interest and Source of Funding:

Dr. A has received honoraria from Company Z. Dr. B is currently receiving a grant (#12345) from Organization Y,  and is on the speaker’s bureau for Organization X – the CME organizers for Company A. For the remaining authors none were declared.

The title page must also include disclosure of funding received for this work from any organizations such as National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).

2. Blinded Manuscript File 

          Abstract: 100 - 200 words, summarizing the manuscript purpose, relevance, and essential points of the manuscript. Research abstracts should summarize the research process and findings. No abbreviations, acronyms, footnotes, or references should be used.

          Text: Organize information under headings and subheadings. Check APA format for headings and subheadings. Do not capitalize subheads.

         Figure Legends 

          References: The style of references is the 6th edition of the Publication Manual of the American Psychological Association (APA). References used in the text are cited by author’s name and date of publication in parentheses (Smith, 2000), with page numbers cited for direct quotations. All references cited in the text must be included on the reference list and authors are responsible for bibliographic accuracy and must check every reference in manuscript and proofread again in page proofs.

The reference list must be arranged alphabetically by first author’s last name.

Examples of correct forms of references:

Standard journal article:
Schmelzer, M., Case, P., Chappell, S., & Wright, K. (2000). Colonic cleansing, fluid absorption, and discomfort following tap water and soapsuds enemas. Applied Nursing Research, 13(2), 83–91.

Complete book:
Hickey, J. V., Ouimette, R. M., & Venegoni, S. L. (Eds). (2000). Advanced practice nursing: Changing roles and clinical applications (2nd ed.). Philadelphia: Lippincott Williams & Wilkins.

Chapter in a book:
Hixon, M. E. (2000). Professional development: Socialization in advanced practice nursing. In J. V. Hickey, R. M. Ouimette, & S. L. Venegoni (Eds.). Advanced practice nursing: Changing roles and clinical applications (2nd ed.), (pp. 46–65). Philadelphia: Lippincott Williams & Wilkins.

Online (Electronic)document: Follow guidelines at www.apastyle.org/elecref.html
Centers for Disease Control & Prevention (CDC). (2001). Twinrix®. Combined Hepatitis A and Hepatitis B Vaccine. Retrieved October 30, 2001, from http://www.cdc.gov/ncidod/diseases/hepatitis/twinrix.htm.

3. Figures: JDNA encourages the use of figures and quality photographs to illustrate key aspects of your manuscript. Refer to the figure in the manuscript as part of a sentence "as in Figure 1" or parenthetically at the end of the sentence (Figure 1).

Four Steps for Submitting Artwork

1. Learn about Digital Art creation. Visit www.lwwonline.com
a. Click “For Authors” and go to the Artwork tab.
b. Here you will also find specific Digital-Imaging Software Instructions to help support your efforts to create perfect images the first time.

2.      Create, Scan and Save your artwork according to the Digital Artwork Guideline Checklist.

3.      Compare your final figure to the Target Digital-Imaging Results listed below.

4.      Upload each figure to Editorial Manager in conjunction with your manuscript text and tables.

Digital Artwork Guideline Checklist
Here are the basics to have in place before submitting your digital art to JDNA:

  • Artwork created as the actual size (or slightly larger) it will appear in the journal. (To get an idea of the size images should be when they print, study a copy of the journal to which you wish to submit. Measure the artwork typically shown and scale your image to match.)
  • Crop out any white or black space surrounding the image.
  • Text and fonts in any figure are one of the acceptable fonts: Helvetica, Times Roman, Symbol, Mathematical PI, and European PI.
  • Line art saved at a resolution of at least 1200 dpi.
  • Images saved at a resolution of at least 300 dpi.
  • Each figure saved as a separate file and saved separately from the accompanying text file.
  • For multi-panel or composite figures only: Any figure with multiple parts should be sent as one file with each part labeled the way it is to appear in print.
  • Cite figures consecutively in your manuscript.
  • Upload figures consecutively to the Editorial Manager web site and number figures consecutively the Description box during upload.

4. Tables: Consecutively numbered, self-explanatory, typed double-spaced with each uploaded as a separate table file, and headed by a brief, but descriptive title. Refer to tables using the same method as referring to figures.

Permissions and Consents: Figures, tables, or quotations must be fully identified with their original author and source. If text material totaling 75 words or more is borrowed, written permission must be obtained for use of the material. Letters granting this permission must be submitted with the manuscript.

Checklist for Authors

  • _____Abstract (100-200 words)
  • _____Title page (include article title, author’s names, credentials, professional position, workplace, mailing address, and email address, Conflict of Interest statement and any funding).
  • _____Article text (double-spaced throughout, 1 inch margins and headings)
  • _____References (double spaced, APA style) Authors are responsible for bibliographic accuracy and must check every reference in manuscript and proofread again in page proofs.
  • _____Tables, figures, illustrations, photographs
  • _____Permission to reproduce previously published material or photographs

Bias-free Language

    1. Do not use language that might imply prejudice against people based on “age, disability, gender, participation in research, racial or ethnic identity, sexual orientation, socioeconomic status, marital status, immigration status, religion" or some combination of these (APA, 2020, p. 131). It is important not to describe a person as their disease (e.g., HIV+ person, drug user) but instead to say a person with a disease (e.g., person living with HIV (PLWH), person who uses drugs). APA style now endorses the use of “they," “them," “their," and “theirs" as generic third-person singular pronouns. Authors should not use “he," “she," “her," or “him" unless they are certain that the person being referred to uses those pronouns. When reporting specifics about study participants, use the labels the participants use for themselves, but do not use “slurs or stigmatizing language" (APA, 2020, p. 133). Be careful of comparing groups of people so as not to marginalize one group and normalize another.
    2. Reporting of Gender (From APA, 2020, p. 138): Authors are strongly encouraged to explicitly designate information about the gender identities of the participants making up their samples (e.g., whether participants are transgender, cisgender, or other gender identities) rather than assuming cisgender identities. Cisgender refers to individuals whose sex assigned at birth aligns with their gender identity. Cisgenderism or cissexism refers to the belief that being cisgender is normative, as indicated by the assumption that individuals are cisgender unless otherwise specified (both terms are in use). Genderism refers to the belief that there are only two genders and that gender is automatically linked to an individual's sex assigned at birth (American Psychological Association of Graduate Students, 2015).
Racial and Ethnic Terms
Correct UsageNotes

Black

white

Capitalize Black, not white. Do not use colors to refer to other groups of people. If using Black, use white, not European etc., and vice versa. Do not use “the Black race" or “the white race".
Asian American, Native American etc.Capitalize. Do not use hyphens.
Black, Nigerian, Kenyan, JamaicanDo not use African American for people in the United States. Do not use African American to refer to people of African ancestry worldwide. Use specific terms such as Nigerian, Kenyan, Jamaican, etc.
Asian, Asian American, Asian Canadian, etc.Asian and Asian American are not synonymous. Asian = people of Asian ancestry from Asia. Asian American = people of Asian ancestry from the United States, etc. Use specific terms when applicable, such as Korean, Japanese, Chinese.
European, European American, whiteBased on location, use the term that is appropriate for the ancestry of the person.
Aboriginal, Indigenous Peoples, Maori, Native AmericanCapitalize. Do not hyphenate.
Native American, Hawaiian Native, Indigenous Peoples of the Hawaiian Islands, Pacific IslanderAll correct for Hawaiian Natives.
People of Middle Eastern and North African originUse the state or nation of origin (e.g., Iraq, Egypt).
People of Hispanic or Latinx EthnicityAsk the person/population you are referring to for the correct designation. Latino might be accepted for those from Latin America. Hispanic may be accepted for those who speak Spanish. [email protected] and Latinx are accepted as gender-neutral terms.
people of color, underrepresented groupsUse these terms for non-white racial and ethnic groups collectively, not “minorities". Do not use “underprivileged".

Note. From APA 7th edition, 2020, chapter on bias-free language.

Sexual Orientation
Correct UsageNotes
sexual orientationDo not use “sexual preference," “sexual identity," “sexual orientation identity". Examples of sexual orientation are: asexual, bisexual, gay, heterosexual, lesbian, pansexual, polysexual, queer, straight. Do not use homosexual.
sexual and gender minoritiesCorrect term for multiple sexual and/or gender minority groups.
LGBTQ etc.If using an acronym, define the components and be consistent throughout the manuscript. Ensure the definition of the acronym is representative of the population to which you are referring.

Note. From APA 7th edition, 2020, chapter on bias-free language.

Socioeconomic Status
Correct UsageNotes
Mothers who receive TANF, people experiencing homelessness, people in transitional housingDo not use “homeless," “poverty stricken," “welfare reliant".
People who have a grade school educationDo not use “high-school dropout," “poorly educated," or “having little education".

Note. From APA 7th edition, 2020, chapter on bias-free language.

English language Standards

Please compose your manuscript in English with United States spelling, grammar, and punctuation conventions. A clear, concise, academic writing style is required. Manuscripts with poor use of the English language are likely to be rejected without further consideration. Options for author services:

  • For authors whose first language is not English in need of language assistance, get help (for a fee) through this portal: http://wkauthorservices.editage.com/
  • For authors who need general help in writing manuscripts: get help from http://authors.lww.com and/or the “Writing in Boxes" e-learning module, which can be found at https://jphmpdirect.com/elearning-module/

Research Communication Services

Authors interested in increasing awareness of their research through video slides, infographics/visual abstracts, news summaries or a plain-language summary can order these directly through the Wolters Kluwer author site with Editage. Graphic and written summaries help readers easily digest your research.

Authors can order the service directly: www.wkauthorservices.editage.com. Visit the website and click on services; on the drop-down menu, select research communication, which will deliver you to a menu page. Select your preferred service and click on Get quote now. Receive professional research support and broaden your reading audience.

Ethical/Legal Considerations

JDNA is a peer-reviewed journal that follows publishing standards set by the American Psychological Association (APA; http://apa.org/) and the Committee on Publication Ethics (COPE; http://publicationethics.org/). Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher.

A submitted manuscript must be an original contribution not previously published in print or online (except as an abstract, preliminary report, thesis, dissertation, or preprint). If an abstract from a poster or presentation has been published in conference proceedings, the abstract and manuscript submitted to JDNA must be substantially different and provide new information for readers. A preprint may have been posted anytime and anywhere, including on scholarly collaboration networks (scns). If the manuscript is accepted, to ensure that readers can find and cite the final published version, we encourage researchers to add the digital object identifier (doi) to the posted preprint version. The submitted paper must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in a similar form, in any language, without the consent of Lippincott Williams & Wilkins.

JDNA will not allow citations to content that are published in journals that are considered to be predatory. As needed, the editors will use the International Academy of Nursing Editors (INANE) nursing journals directory (available at https://nursingeditors.com/journals-directory/) and the Directory of Open Access Journals (DOAJ; available at https://doaj.org), as well as PubMed, Medline, and other resources to determine the legitimacy of the journals included in a manuscript's reference list. If an author is suspected of citing predatory content in their manuscript, the editor will ask the author to remove that citation and content from the submission.

Research Participant Anonymity and Informed Consent

It is the responsibility of the author(s) to ensure protection of research participant anonymity and to verify that human subjects investigations were conducted with informed consent, followed all guidelines for human subjects investigations required by the institution(s) with which the authors are affiliated, and, at minimum, in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for investigations involving human subjects, available at http://www.wma.net/en/30publications/10policies/b3/index.html

Permissions

When using other authors' works, (e.g., quoted text, modifying or adapting a published table or figure, or re-publishing a tool or questionnaire), even if the source material is not copied exactly, authors must submit written permission from the copyright owner (usually the publisher), along with complete details about the source. (Often the required citation is prescribed by the copyright holder.) Merely referencing the original source may not be enough. It is the sole responsibility of the author(s) to obtain required permissions and to pay all permissions fees that are required by the copyright owner.

Copyright  

Each author must complete and submit the journal's copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the ICMJE recommendations, "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (www.icmje.org/update.html).

Compliance with NIH/other research funding agency accessibility requirements

Many funding agencies require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is publicly accessible online without charge. As a service to our authors, LWW will identify National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article to PubMed Central based on research funded in whole or in part by the National Institutes of Health, Welcome Trust, Howard Hughes Medical Institute, or other funding agencies. The Copyright Transfer Agreement document provides the mechanism for this process.

Data Sharing and Transparency

“Authors are expected to retain the data associated with a published article in accordance with institutional requirements; funder requirements; participant agreements; and, when publishing in an APA journal . . ." (APA, 2020, p.13). This allows for open science and other researchers to confirm the reported analyses. Authors can place their anonymized data (participant identity must be protected) in repositories for archival, providing a link and DOI to those data or manage requests personally, as received. “Data-sharing arrangements must be entered into with proper consideration of the rights of the copyright owner, participants' consent, requirements of funding agencies, requirements of IRBs and other ethics committees that provided permission to conduct the study, and rules promulgated by the employer of the holder of the data" (APA, 2020, p. 15). Authors bear any costs associated with data sharing.

Plagiarism Prevention: JDNA uses iThenticate© to detect similarities between submitted papers and previously published materials, including information published on the Internet. We will not review submissions with excessive similarities to other publications, including those authored by the individuals submitting the manuscript to JDNA (self-plagiarism).

Multiple Publications from one Study: It is not uncommon to produce more than one paper from one data set/study. In these circumstances, each paper must represent a clearly unique use of the data and be presented in a manner that avoids any perception of self-plagiarism. JDNA requires that authors who submit a paper using data from a previously-published work discuss the following in the body of the manuscript: (a) information about the previously-published work, including a citation and reference to the original article, as well as citations and references to other articles published from the original data, as pertinent to the submitted manuscript; (b) how the data used in the submission were analyzed and how (or if) the current analysis differs from analysis in the original article; (c) a description of the participants in the submission and how (or if) the participants differ from those in the original article; and (d) a clear and specific statement about how the submitted work differs from other publications from the study and why the further use of these data is appropriate.

Open Access

Authors of accepted peer-reviewed manuscripts have the option of paying a fee to allow perpetual unrestricted online access to the published article to readers globally. To ensure that this option has no influence on the peer review and acceptance process, authors may select the open access option at the point of acceptance. All submitted manuscripts are subject to the journal's standard peer-review process and will be accepted or rejected based on their own merit.

An article processing charge (APC) is requested upon acceptance of the manuscript and should be paid within 30 days by the author, funding agency, or institution. Payment must be processed for the article to be published open access. For a list of journals and pricing, please visit the Wolters Kluwer Open Health Journals page.

Authors Retain Copyright

Authors retain the copyright for all articles they opt to publish as open access. Authors grant LWW an exclusive license to publish the article and the article is made available under the terms of a Creative Commons user license. Please visit the Open Access Publication Process page for more information.

Creative Commons License

Open access articles are freely available to read, download, and share from the time of publication under the terms of the Creative Commons License Attribution-NonCommerical No Derivative (CC BY-NC-ND) license. This license does not permit reuse for any commercial purpose, nor does it permit the reuse or modification of individual elements of the work (i.e., figures, tables) in the creation of derivative works without specific permission.

Compliance with Funder Mandated Open Access Policies

An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution (CC BY) license may meet that requirement through the available open access license for approved funders. Information about the approved funders can be found at http://www.wkopenhealth.com/inst-fund.php.

FAQ for Open Accesshttp://www.wkopenhealth.com/openaccessfaq.php

Clinical Trials

As of June 1, 2019, JDNA will require that clinical trials submitted for review and possible publication are registered in clinicaltrials.gov (or equivalent) prior to submission of the paper. As of June 1, 2021, JDNA will require that any submissions coming from clinical trials are registered before enrollment of the first patient. The registration number should be included in a note on the title page.

The National Institutes of Health define a clinical trial as, “a research study in which one or more human participants are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes." (https://grants.nih.gov/policy/clinical-trials/CT-Definition-Case-Studies_1.17.18.pdf). Cohort, retrospective, and observational studies without an intervention do not require registration. Studies of human subjects with prospective assignment of an intervention by the investigators, however, must be registered, regardless of the size of the trial (http://www.who.int/ictrp/en).

All research involving human participants must include in the “methods" section that institutional review board (IRB) approval was obtained, or, if applicable, why an exemption was granted. In addition, the name of the IRB or ethics review committed must be specified.

Supplemental Digital Content: Size and File Type Requirements

Authors may submit supplemental digital content (SDC) to enhance the manuscript text. SDC will be considered for online-only posting. SDC may include the following types of content: text documents, graphs, tables, figures, graphics, illustrations, audio, and video. All SDC will be peer reviewed.

SDC files should be no larger than 10 MB each. Documents, graphs, and tables may be presented in any format. Figures, graphics, and illustrations should be submitted with the following file extensions: .tif, .eps, .ppt, .jpg, .pdf, .gif. Audio files should be submitted with the following file extensions: .mp3, .wma. Video files should be submitted with the following file extensions: .wmv, .mov, .qt, .mpg, .mpeg, .mp4. Video files should also be formatted with a 320 X 240 pixel minimum screen size. For more information, please review LWW's requirements for submitting supplemental digital content: http://links.lww.com/A142

Citing SDC in text and master list compilation

Cite all SDC consecutively in the text. Citations should: include the type of material submitted, be clearly labeled as "Supplemental Digital Content," include a sequential number, and provide a brief description of the supplemental content. Audio and video citations should also include the length (in minutes) and size (in MB) of the file.

Provide a list of all SDC in-text citations, in the order in which they were cited in the text, immediately following your list of references. Citations listed on the SDC page must be numbered to match the citations from the text. Include a title and a brief summary of the content. For audio and video files, also include the author's name, videographer, participants, length (in minutes), and size (in MB).

Follow the format below for SDC citations in text and on the citation summary page after your reference list. This will allow production staff to slot the URL they create with the SDC file into the article. The legend citation page after the reference list helps production easily see how many SDC items to look for in the text. The legend will be removed before publication; it is only there as a marker for production.

Example of Text Citation of SDC: 

"Motivational interviewing includes a number of counseling skills and motivational techniques" (See Video, Supplemental Digital Content 1, which shows a motivational interviewing session with explanatory notes, 5 minutes, 10MB). Motivational interviewing session in which a nurse counsels a patient about adherence to antiretroviral therapy using reframing, active listening, focused questioning techniques, ...

Example of Master List Compilation of all SDC Citations at end of Manuscript:

Video, Supplemental Digital Content 1, shows a patient having a Basal Cell Carcinoma removed from their scalp.

  • Author: NAME GOES HERE
  • Videographer: NAME GOES HERE
  • Participants: Nurse and patient
  • Length: 6.2 minutes
  • Size: 10MB

After Acceptance 

Page proofs and corrections

Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. An email will be sent with instructions on how to access the Portable document format (PDF) files of the typeset pages will be using your Editorial Manager login and password. Complete instructions will be provided with the email for downloading and submitting the corrected page proofs to the publisher. It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections returned within 48 hours of receipt, as requested in the cover letter accompanying the page proofs.

Publication Ahead-of-Print (PAP)

PAP provides rapid access to important new data, and enables authors to cite their work promptly. All accepted submissions with completed copyright and disclosure forms will be published as PAP after the author has reviewed the page proofs. To avoid errors and delays, submitted manuscripts must be carefully proofed by authors during the page proof stage.

Print Publication

Most, but not all, accepted manuscripts are published in print in our bi-monthly issues. Some manuscripts, due to length or urgent need for publication, are published online only and included in the table of contents of a print issue.

Reprints

Authors are emailed a reprint notification letter with a link to the order form soon after their article publishes in the journal (and not before). Questions about this can be directed to [email protected].



Queries should be sent to: Journal of Dermatology Nurses’ Association
Melissa Derby
Managing Editor